Cost-efficient higher-order crossover designs for two-treatment clinical trials

Pharmaceutical Statistics

Volumn 4, Issue 4, 2005, Pages 245-252

  Yuan, Ying ^a   Zhou, Jihao ^a,b  

^a PFIZER INC   (United States)

^b ALLERGAN INC   (United States)

Author keywords

Cost efficiency; Higher order crossover design; Simple carry over effect; Steady state carry over effect

Indexed keywords

DRUG;

ARTICLE; CLINICAL RESEARCH; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DRUG RESEARCH; NORMAL DISTRIBUTION; SAMPLE SIZE; STATISTICAL ANALYSIS; STATISTICAL MODEL; STEADY STATE; VARIANCE;

EID: 29544438869     PISSN: 15391604     EISSN: None     Source Type: Journal    
DOI: 10.1002/pst.186     Document Type: Article

References (15)

1. Jones B, Kenward MG. Design and analysis of cross-over trials (2nd edn). Chapman & Hall/CRC: Boca Raton, FL, 2003.
2. Senn S. Cross-over trials in clinical research. Wiley: Chichester, 1993.
3. Chow S-C, Liu J-P. Design and analysis of bioavailability and bioequivalence stuides. Marcel Dekker: New York, 2000.
4. Laska E, Meisner M, Kushner HB. Optimal crossover designs in the presence of carry-over effects. Biometrics 1983; 39:1087-1091.
5. Kershner RP, Federer WT. Two-treatment crossover designs for estimating a variety of effects. Journal of the American Statistical Association 1981; 76:612-619.
6. Cheng C, Wu C. Balanced repeated measurements designs. Annals of Statistics 1980; 8:1272-1283.
7. Laska EM, Meisner M. A variational approach to optimal two-treatment crossover designs: applications to carry-over effect models. Journal of the American Statistical Association 1985; 80:704-710.
8. Brown BW. The crossover experiment for clinical trials. Biometrics 1980; 36:69-79.
9. Carriere KC, Huang R. Crossover designs for two-treatment clinical trials. Journal of Statistical Planning and Inference 2000; 87:125-134.
10. Fleiss J. Letter to the editor: On multiperiod crossover studies. Biometrics 1986; 42:449-450.
11. Fleiss J. A critique of recent research on the two-treatment cross-over design. Controlled Clinical Trials 1989; 10:237-243.
12. Senn S. Is the simple carry-over model useful? Statistics in Medicine 1992; 11:715-726.
13. Senn S, Lambrou D. Robust and realistic approach to carry-over. Statistics in Medicine 1998; 17: 2849-2864.
14. Matthews JNS. Modelling and optimality in the design of crossover studies for medical applications. Journal of Statistical Planning and Inference 1994; 42:89-108.
15. Matthews JNS. Multi-period cross-over trials. Statistical Methods in Medical Research 1994; 3: 383-405.